Smaller infarct size with ticagrelor vs. clopidogrel in STEMI patients: Insights from cardiac magnetic resonance
PLOS One · 2025
DOI: 10.1371/journal.pone.0328114 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, 2025. Verfasst von Francisco A Fonseca und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Division, Universidade Federal de São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Platelet Aggregation Inhibitors, Adenosine, Ticlopidine. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FAPESP, AstraZeneca, INCT /CNPq.
Abstract (Originalsprache)
Background
Ticagrelor has many protective cardiovascular properties beyond potent antiplatelet action. This study aimed to compare the effects of ticagrelor versus clopidogrel on infarcted mass, quantified by cardiac magnetic resonance (CMR), in patients with ST-segment elevation acute myocardial infarction (STEMI).
Methods
Adult patients of both sexes with STEMI under a pharmaco-invasive strategy were included (n = 225). Patients were treated by thrombolysis within six hours of symptom onset and underwent angiography with percutaneous coronary interventions, when needed, within the first 24 hours. Prior to the invasive procedures, patients were randomly assigned to receive either ticagrelor or clopidogrel using a centralized computerized system. Patients were followed on a weekly basis to optimize their medical therapy.
Results
After 30 days, CMR was performed and a smaller percentage of left ventricular infarcted mass was found with ticagrelor (p = 0.012), despite similar angiographic findings at baseline (Syntax score, Gensini score, culprit artery, TIMI flow, and myocardial blush). At 30 days, left ventricular ejection fraction (LVEF) was comparable between groups. Still, the K-means algorithm displayed more homogeneous responses for smaller infarcted mass and better LVEF among those patients treated with ticagrelor. Standard lipid panel and most inflammatory parameters were similar at baseline and after 30 days. However, lower high-sensitivity troponin T and high-sensitivity C-reactive protein levels were found in samples collected from patients treated with ticagrelor on the first day of STEMI.
Conclusion
In patients with STEMI under a pharmaco-invasive strategy, therapy with ticagrelor was associated with a smaller infarct size than clopidogrel.
Trial registration
Clinicaltrials.gov ( NCT02428374 ).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cardiology Division, Universidade Federal de São Paulo, São Paulo, Brazil.
- Hospital Israelita Albert Einstein, São Paulo, Brazil.
- Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.
- Instituto de Física, Universidade São Paulo, São Paulo, Brazil.
- Universidade Santo Amaro, São Paulo, Brazil.
- Brazilian Network of Collaboration and Knowledge Advancement on Severe Hypertriglyceridemia - Hypertri Brazil Network, Casa Dos Raros, Porto Alegre, Brazil.
ORCID-Profile: Francisco A Fonseca, Antonio M Figueiredo Neto, Henrique T Bianco, Igor R M Batista, Maria C Izar
Förderung
- FAPESP
- AstraZeneca
- INCT /CNPq
- INCT/FAPESP
- INCT/CAPES
- INCT-FCx
Zitieren
APA
Fonseca, F. A., Caixeta, A., Szarf, G., Pinto, I., Figueiredo Neto, A. M., França, C. N., Bianco, H. T., Fonseca, H. A., Bacchin, A. S., Birtche, M., Batista, I. R. M., Izar, M. C., & BATTLE-AMI investigators (2025). Smaller infarct size with ticagrelor vs. clopidogrel in STEMI patients: Insights from cardiac magnetic resonance. PLOS One. https://doi.org/10.1371/journal.pone.0328114
Vancouver
Fonseca FA, Caixeta A, Szarf G, Pinto I, Figueiredo Neto AM, França CN, et al. Smaller infarct size with ticagrelor vs. clopidogrel in STEMI patients: Insights from cardiac magnetic resonance. PLOS One. 2025. doi:10.1371/journal.pone.0328114
BibTeX
@article{Fonseca2025,
author = {Fonseca, Francisco A and Caixeta, Adriano and Szarf, Gilberto and Pinto, Ibraim and Figueiredo Neto, Antonio M and França, Carolina N and Bianco, Henrique T and Fonseca, Henrique A and Bacchin, Amanda S and Birtche, Michelle and Batista, Igor R M and Izar, Maria C and BATTLE-AMI investigators, BATTLE-AMI investigators},
title = {Smaller infarct size with ticagrelor vs. clopidogrel in STEMI patients: Insights from cardiac magnetic resonance},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0328114}
}
EUVIMED